» Authors » Ying Ping

Ying Ping

Explore the profile of Ying Ping including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 148
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Guo L, Ping Y
PLoS One . 2024 Sep; 19(9):e0307171. PMID: 39302981
Modern medical technology innovation is a critical safeguard for human health, while a significant number of developing nations are confronted with the challenge of biopharmaceutical technological advancement. To investigate the...
2.
Wang X, Chen T, Ping Y, Dai Y, Yu P, Xie Y, et al.
Small . 2023 Dec; 20(20):e2307985. PMID: 38084466
Genetic variations are always related to human diseases or susceptibility to therapies. Nucleic acid probes that precisely distinguish closely related sequences become an indispensable requisite both in research and clinical...
3.
Chen J, Ping Y, Jia J, Li G
PLoS One . 2023 Oct; 18(10):e0292265. PMID: 37824536
More than 40 years of urbanization in China has brought rapid economic growth, but the uneven development of region and how to achieve common prosperity through urbanization remain a serious...
4.
Duan X, Huang L, Wang X, Ping Y, Yu P, Liu W, et al.
J Clin Lab Anal . 2023 Sep; 37(15-16):e24956. PMID: 37661301
Background: Sampling and testing for SARS-CoV-2 is a widely recognized method for identifying patients with COVID-19. However, there is limited research available on the stability of nucleic acids in viral...
5.
Xie Y, Ping Y, Yu P, Liu W, Chen X, Wang Q, et al.
Heliyon . 2023 Jul; 9(6):e17003. PMID: 37484218
Background: It has been confirmed that the connective tissue growth factor (CTGF) gene rs9402373 polymorphism is associated with fibrotic and inflammatory diseases. However, studies on the relationship between polymorphisms in...
6.
Yu P, Dai Y, Zhuang T, Yue X, Chen Y, Wang X, et al.
Oxid Med Cell Longev . 2022 Aug; 2022:8761112. PMID: 36035209
Background: The acquisition of castration resistance is lethal and inevitable in most prostate cancer patients under hormone therapy. However, effective biomarkers and therapeutic targets for castration-resistant prostate cancer remain to...
7.
Dai Y, Wang Y, Cao Y, Yu P, Zhang L, Liu Z, et al.
Front Oncol . 2021 Dec; 11:777684. PMID: 34900726
Introduction: Prostate cancer (PCa) is one of the most frequently diagnosed cancers and the leading cause of cancer death in males worldwide. Although prostate-specific antigen (PSA) screening has considerably improved...
8.
Cao Y, Dai Y, Zhang L, Wang D, Hu W, Yu Q, et al.
J Inflamm Res . 2021 Dec; 14:6409-6419. PMID: 34880643
Background: Fecal biomarkers have emerged as one of the most useful tools for clinical management of inflammatory bowel disease (IBD). Oncostatin M (OSM), like fecal calprotectin (FC), is highly expressed...
9.
Cao Y, Dai Y, Zhang L, Wang D, Yu Q, Hu W, et al.
Clin Biochem . 2021 Nov; 100:35-41. PMID: 34843732
Background: Although endoscopy is the gold standard to assess disease activity and infliximab efficacy in inflammatory bowel disease (IBD), the invasive, costly, and time-consuming procedure limits its routine applications. We...
10.
Sun T, Qu S, Huang T, Ping Y, Lin Q, Cao Y, et al.
J Clin Lab Anal . 2021 Oct; 35(11):e24051. PMID: 34651352
Background: Acute kidney injury (AKI) was a common clinical complication among critically ill patients in Intensive Care Unit with high morbidity and mortality. Human liver fatty acid-binding protein (L-FABP) as...